Alamar Biosciences, Inc. (California) (ALMR)
30.83
-0.93
(-2.93%)
USD |
NASDAQ |
Nov 13, 16:00
30.83
0.00 (0.00%)
After-Hours: 19:59
Alamar Biosciences EPS Diluted (Quarterly) : -0.1921 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.1921 |
| June 30, 2026 | -0.1902 |
| March 31, 2026 | -0.3077 |
| Date | Value |
|---|---|
| September 30, 2025 | -0.1154 |
| June 30, 2025 | -0.1013 |
| March 31, 2025 | -0.1105 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Personalis, Inc. | -0.3153 |
| 10X Genomics, Inc. | -0.1485 |
| Champions Oncology, Inc. | -0.0306 |
| Medpace Holdings, Inc. | 4.845 |
| Avantor, Inc. | 0.2987 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.34M |
| Revenue (Quarterly) | 33.54M |
| Total Expenses (Quarterly) | 46.89M |
| Enterprise Value | 2.022B |
| Gross Profit Margin (Quarterly) | 61.54% |
| Profit Margin (Quarterly) | -39.77% |
| Earnings Yield | -2.61% |
| Normalized Earnings Yield | -2.286 |